Literature DB >> 14556919

Neuropsychological functioning following systemic treatment in women treated for breast cancer: a review.

R Morse1, J Rodgers, M Verrill, K Kendell.   

Abstract

The aim of this review was to evaluate the effect of treatment and illness-related factors on neuropsychological functioning in women treated for breast cancer. Eight studies were identified examining neuropsychological test performance following systemic treatment. Six of the eight studies suggest that neuropsychological functioning may be impaired following treatment. However, there are a number of important methodological issues which limit interpretation of these results. Therefore, it is unclear whether neuropsychological outcome differs according to a range of treatment, biomedical and psychological factors. Larger samples with longitudinal follow-up are required in order to examine the treatment-related factors that best predict cognitive deficits.

Entities:  

Mesh:

Year:  2003        PMID: 14556919     DOI: 10.1016/s0959-8049(03)00600-2

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  12 in total

1.  Attitudes toward information about genetic risk for cognitive impairment after cancer chemotherapy: breast cancer survivors compared with healthy controls.

Authors:  Michael A Andrykowski; Jessica L Burris; Erin Walsh; Brent J Small; Paul B Jacobsen
Journal:  J Clin Oncol       Date:  2010-05-24       Impact factor: 44.544

2.  Breast cancer morbidity: questionnaire survey of patients on the long term effects of disease and adjuvant therapy.

Authors:  Stefan Feiten; Jan Dünnebacke; Jochen Heymanns; Hubert Köppler; Jörg Thomalla; Christoph van Roye; Diana Wey; Rudolf Weide
Journal:  Dtsch Arztebl Int       Date:  2014-08-04       Impact factor: 5.594

3.  Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma.

Authors:  Kristine A Donovan; Brent J Small; Michael A Andrykowski; Frederick A Schmitt; Pamela Munster; Paul B Jacobsen
Journal:  Cancer       Date:  2005-12-01       Impact factor: 6.860

4.  Cognitive Effects of Systemic Therapy in Patients with Breast Cancer.

Authors:  Ute Berndt; Bernd Leplow; Eva Kantelhardt; Christoph Thomssen
Journal:  Breast Care (Basel)       Date:  2009-06-17       Impact factor: 2.860

5.  Benzyl isothiocyanate inhibits basal and hepatocyte growth factor-stimulated migration of breast cancer cells.

Authors:  Eun Ji Kim; Soon Ju Eom; Ji Eun Hong; Jae-Yong Lee; Myung-Sook Choi; Jung Han Yoon Park
Journal:  Mol Cell Biochem       Date:  2011-09-03       Impact factor: 3.396

6.  Immune response, depression and fatigue in relation to support intervention in mammary cancer patients.

Authors:  Christina Lindemalm; Fariba Mozaffari; Aniruddha Choudhury; Helena Granstam-Björneklett; Mats Lekander; Bo Nilsson; Marja-Leena Ojutkangas; Anders Osterborg; Leif Bergkvist; Håkan Mellstedt
Journal:  Support Care Cancer       Date:  2007-06-12       Impact factor: 3.603

7.  Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer.

Authors:  K Ribi; J Aldridge; K-A Phillips; A Thompson; V Harvey; B Thürlimann; F Cardoso; O Pagani; A S Coates; A Goldhirsch; K N Price; R D Gelber; J Bernhard
Journal:  Br J Cancer       Date:  2012-04-24       Impact factor: 7.640

Review 8.  Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events.

Authors:  Ana Dias-Carvalho; Mariana Ferreira; Rita Ferreira; Maria de Lourdes Bastos; Susana Isabel Sá; João Paulo Capela; Félix Carvalho; Vera Marisa Costa
Journal:  Arch Toxicol       Date:  2021-11-02       Impact factor: 5.153

9.  TJ-41 Induces Apoptosis and Potentiates the Apoptotic Effects of 5-FU in Breast Cancer Cell Lines.

Authors:  Suresh Volate; Robert Hudson; Desuo Wang; Stephanie Muga; Michael Wargovich
Journal:  J Oncol       Date:  2009-08-20       Impact factor: 4.375

10.  Why, After Chemotherapy, is it Necessary to Assess Memory Using Translational Testing?

Authors:  Summer F Acevedo
Journal:  Breast Cancer (Auckl)       Date:  2012-11-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.